Investigate / reported ownership
DVA
Davita Inc
2 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning DVA?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Warren Buffett | 2.1% | 40q | $6.43B | 28,880,209 |
| 2 | Joel Greenblatt | <0.1% | 38q | $44M | 199,862 |
Go beyond ownership.
DaVita’s largest business provides U.S. dialysis and related laboratory services for patients with chronic kidney failure, within its wider kidney-care platform.
Question to investigate: Can DaVita sustain dialysis profitability if commercial payor terms or patient mix become less favorable?
Company research reviewed 2026-10-02; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow DVA
Email me only when a reviewed weekly edition contains a material new decision about DVA: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 23918K108. No current price, valuation or manager motive is inferred.